The Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (2002)
BACKGROUND: Highly selective cyclooxygenase-2 (COX-2) inhibitors have recently been approved for the treatment of colon cancer, breast cancer, urinary bladder cancer, and skin cancer. For the highly selective COX-2...